Related Experiment Video

Updated: Jun 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Current views on lipid metabolism: statin-induced myopathy]

L L Teichmann1, M Fleck

  • 1Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA.

Zeitschrift Fur Rheumatologie
|September 24, 2010
PubMed

Insights

Statins, used to prevent cardiovascular events, can cause muscle damage (myopathy) in patients with rheumatic diseases. Monitor for muscle symptoms and elevated creatine kinase levels, especially if risk factors are present.

Area of Science:

  • Cardiology
  • Rheumatology
  • Pharmacology

Context:

  • Cardiovascular diseases (CVDs) are leading causes of death in Germany.
  • Patients with inflammatory rheumatic diseases have a higher prevalence of CVDs.
  • Statins are crucial for CVD prophylaxis but carry a risk of myopathy.

Purpose:

  • To review the potential for statin-induced myopathy in patients with inflammatory rheumatic diseases.
  • To identify risk factors and clinical manifestations of statin-induced myopathy.
  • To provide guidance on monitoring and managing statin-induced myopathy.

Summary:

  • Statin therapy, while beneficial for cardiovascular event prevention, can lead to myopathy, ranging from muscle enzyme elevation to rhabdomyolysis.
  • This side effect is rare but risk factors like drug interactions, dosage, patient characteristics, and comorbidities increase susceptibility.
  • Myopathy typically manifests within six months of statin initiation.
  • Monitoring muscle enzymes is not routinely recommended for asymptomatic patients but is essential if muscle symptoms arise.

Impact:

  • Highlights the importance of vigilant monitoring for statin-induced myopathy in at-risk populations, particularly those with rheumatic conditions.
  • Emphasizes the need for prompt discontinuation of statin therapy and diagnostic evaluation upon detection of significant muscle enzyme elevation (e.g., >10-fold increase in creatine kinase).
  • Informs clinical practice regarding the safe and effective use of statins in patients with inflammatory rheumatic diseases and cardiovascular risk.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...